Changes

Jump to navigation Jump to search
1,431 bytes added ,  15:37, July 28, 2020
adding a new topic

On 2 April 2020, Advance Nanotek,[https://www.advancenanotek.com/] an Australian producer of zinc oxide, filed a joint patent application with AstiVita Limited,[https://www.astivita.com.au/] for an antiviral composition that included various oral care products [http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2020900820] containing hinokitiol as a vital component. The brand that is now incorporating this new invention is called Dr. ZinX and is likely to release its Zinc + Hinokitiol combination products in 2020.[https://www.asx.com.au/asxpdf/20200520/pdf/44hzh0v8bqgvlx.pdf][https://www.drzinx.com/] On 18 May 2020, Dr. ZinX published test results for a “Quantitative suspension test for the evaluation of hinokitol's virucidal properties in the medical area” [https://www.asx.com.au/asxpdf/20200520/pdf/44hzh0v8bqgvlx.pdf][https://www.drzinx.com/testresults] declaring a ‘3.25 log’ reduction (99.9% reduction) for a neat concentration in 5 minutes against COVID-19 surrogate Feline Coronavirus.[https://www.tga.gov.au/surrogate-viruses-use-disinfectant-efficacy-tests-justify-claims-against-covid-19] Zinc is considered to be an essential dietary supplement and trace element in the body. Globally it is estimated that 17.3% of the population has inadequate Zinc intake.[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510072/][https://academic.oup.com/jn/article/132/11/3422/4687273]
4

edits

Navigation menu